These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Cardiac magnetic resonance and uremic cardiomyopathy]. Di Lullo L; Gorini A; Rivera R; De Pascalis A; Bellasi A; Russo D; Barbera V; Ronco C; Balducci A; Santoboni A G Ital Nefrol; 2014; 31(6):. PubMed ID: 25504164 [TBL] [Abstract][Full Text] [Related]
5. [Imaging modalities for evaluation of cardiac function in patients with chronic hemodialysis]. Komiyama N Nihon Rinsho; 2004 Jun; 62 Suppl 6():92-5. PubMed ID: 15250275 [No Abstract] [Full Text] [Related]
7. Is uremic cardiomyopathy a direct consequence of chronic kidney disease? Chinnappa S; Hothi SS; Tan LB Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):127-30. PubMed ID: 24404903 [TBL] [Abstract][Full Text] [Related]
8. [Cardiomyopathy in uremia: hemodynamic and metabolic aspects (author's transl)]. Drüeke T; Le Pailleur C Nephrologie; 1981; 2(2):63-6. PubMed ID: 7290302 [TBL] [Abstract][Full Text] [Related]
9. Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy. Wang X; Liu J; Drummond CA; Shapiro JI Expert Opin Ther Targets; 2017 May; 21(5):531-541. PubMed ID: 28338377 [TBL] [Abstract][Full Text] [Related]
10. Uremic syndrome and end-stage renal disease: physical manifestations and beyond. Chikotas N; Gunderman A; Oman T J Am Acad Nurse Pract; 2006 May; 18(5):195-202. PubMed ID: 16681706 [TBL] [Abstract][Full Text] [Related]
11. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119 [TBL] [Abstract][Full Text] [Related]
12. Uremic cardiomyopathy and insulin resistance: a critical role for akt? Semple D; Smith K; Bhandari S; Seymour AM J Am Soc Nephrol; 2011 Feb; 22(2):207-15. PubMed ID: 20634295 [TBL] [Abstract][Full Text] [Related]
13. Altered relative concentrations of high-energy phosphates in patients with uraemic cardiomyopathy measured by magnetic resonance spectroscopy. Patel RK; Mark PB; Macnaught G; Stevens KK; McQuarrie EP; Steedman T; Gillis K; Dargie HJ; Jardine AG Nephrol Dial Transplant; 2012 Jun; 27(6):2446-51. PubMed ID: 22241795 [TBL] [Abstract][Full Text] [Related]
15. The general picture of uremia. Almeras C; Argilés A Semin Dial; 2009; 22(4):329-33. PubMed ID: 19708976 [TBL] [Abstract][Full Text] [Related]
16. Implications of uremic cardiomyopathy for the practicing clinician: an educational review. Hiraiwa H; Kasugai D; Okumura T; Murohara T Heart Fail Rev; 2023 Sep; 28(5):1129-1139. PubMed ID: 37173614 [TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]